Clinical Trial Update: RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing cefiderocol to best available therapy for bloodstream infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infections

Drugs mentioned

• Cefiderocol (cefiderocol)

Snippet

Sponsor: The University of Queensland | Conditions: Bloodstream Infections | Phase 2 | Status: COMPLETED